First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study

First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study

Patients with non-obstructive lipid-rich plaques (LRPs) on combined intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS) are at high risk for future events. Local pre-emptive percutaneous treatment of LRPs with a paclitaxel-eluting drug-coated balloon (PE-DCB) may be a novel therape...

Full description

Bibliographic Details
Main Authors: Anna van Veelen, I. Tarik Küçük, Federico H. Fuentes, Yirga Kahsay, Hector M. Garcia-Garcia, Ronak Delewi, Marcel A. M. Beijk, Alexander W. den Hartog, Maik J. Grundeken, M. Marije Vis, José P. S. Henriques, Bimmer E. P. M. Claessen
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Journal of Clinical Medicine
Subjects:
vulnerable plaque
drug-coated balloon
intracoronary imaging
intravascular ultrasound
near-infrared spectroscopy
non-ST-segment elevation acute coronary syndrome
Online Access:https://www.mdpi.com/2077-0383/12/18/5807

Internet

https://www.mdpi.com/2077-0383/12/18/5807

Similar Items